Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease - Test2 - elhamkhani - TriplyDB

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

http://www.wikidata.org/entity/Q37486254

about

Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy.Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study Relationship between hippocampal structure and memory function in elderly humans.Tensor-based morphometry with stationary velocity field diffeomorphic registration: application to ADNI MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements Improved myo-inositol detection through Carr-Purcell PRESS: a tool for more sensitive mild cognitive impairment diagnosis.Biological markers for early detection and pharmacological treatment of Alzheimer's disease.Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.Altered Microstructural Caudate Integrity in Posttraumatic Stress Disorder but Not Traumatic Brain Injury.Strategies for molecular imaging dementia and neurodegenerative diseases.Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment.1H magnetic resonance spectroscopy in dementia.Poor prognosis osteosarcoma: new therapeutic approach.Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease Bigger is better! Hippocampal volume and declarative memory performance in healthy young men.EFNS task force: the use of neuroimaging in the diagnosis of dementia.Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 tesla.Susceptibility-Weighted Magnetic Resonance Imaging in the Evaluation of Dementia.Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.Volumetric brain changes in thalamus, corpus callosum and medial temporal structures: mild Alzheimer's disease compared with amnestic mild cognitive impairment.Cognitive impairment: classification by 1H magnetic resonance spectroscopy.Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.Mini-Mental State Examination and proton spectroscopy of the posterior cingulate in Alzheimer disease.Memory performance in multiple sclerosis patients correlates with central brain atrophy.Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment.Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.

P2860

Q30630699-42810624-3497-40C6-96F2-56D75D77AED6 Q30981669-8247AF91-B588-4FDE-A4DA-06E1CE017EA9 Q30989929-1A97D0BA-10FB-4C7D-BA69-7DCD439BE5FB Q30994832-1366E146-2463-4042-85A0-2388F794BB62 Q30996805-E245259F-D66E-4BAC-A23B-3D3DFA7FFE98 Q31152538-A9762F1A-6BBC-4AF2-8B45-023A50295D98 Q31159878-67EE6BDA-D1F7-44B3-AAC9-91C94FF3AF5A Q33271816-23FAD088-24DB-4447-80F2-8B114E431150 Q33557868-E3452660-695E-4AE9-81CB-11CB9A8C3235 Q34145380-E0AB32F2-DFBA-4989-A91D-97C09AC0C89C Q34247831-F24677A7-BFFA-4AF2-9261-6F00CCACBCA5 Q34547233-9329FFF3-EC70-42CC-8430-5FA1707BE539 Q34746761-4488E93B-9AEC-4020-9AE1-EEC01A04B5CF Q34770643-51C132F0-995B-4D40-862A-9ACD63F09492 Q35038099-CA2E8AAF-8133-41B6-A150-90B63A80A8CA Q35237100-87B551A5-7F5A-499A-8F0C-AAE7AA06A6E1 Q35319467-5C57D74B-CB39-46E9-9867-E0FBB6C9C20D Q35677174-CEE7C612-E0A8-412C-B52C-5EE942D452ED Q35781558-3E9F6961-4844-43A2-B14C-3F140254D511 Q36257224-C357D14A-A6FC-49E0-B4B1-F110C416F4C9 Q36257692-C1F33BB0-E75C-4524-8ABF-ADE2C61BA9C7 Q36853915-68360BF1-BD64-4AEC-90DF-ED29C58A4F1B Q37131880-E3A1E8B9-F89C-493B-865C-46207E267BB4 Q37150637-1EE8D8BA-8F76-41C6-B8C7-124CF6176380 Q37188469-2227E58B-743F-4CEC-A358-5BAA1FA6C860 Q37398634-716017A5-3605-4A4A-B2BA-B2ECDC3E6732 Q37470671-02EB898E-8D0E-4E33-B15F-45505339F60D Q38035398-C57D50AF-E474-46CA-9ECB-009F3641B317 Q41862490-A57336C4-5C7E-4A4D-BD4B-6EE622676A8A Q42039062-4EED888B-0663-4D41-B92A-53A6314CC710 Q43645204-A70960F9-B20E-4149-B8A2-54BE0E7D1F80 Q44322682-6B18268A-930C-4B75-8311-13C170DC196E Q44791946-3BB6FE23-8E3A-478A-9536-01F5478B0787 Q44937365-71A493C3-1576-4A52-B847-E3FB31D62C40 Q45732943-BEB607F6-4780-45B1-8949-ADA91A2BB42D Q45905949-82FA87D5-13CE-4136-B7B7-C58321065441 Q48450471-FFDAAF3D-E526-4C73-AC17-5A0A44E27B64 Q48665796-86974D56-43DE-47A6-9B29-1B1CF73F0173 Q48670459-AC019FCB-F72E-49BA-94E8-B26568C2B10F Q48896363-85841CB1-A716-41F4-B774-F89146375D0D

P2860

Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease

http://www.wikidata.org/entity/Q37486254

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2002

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative diagnostic utility ...... irment and Alzheimer's disease

@en

Comparative diagnostic utility ...... rment and Alzheimer's disease.

@nl

type

label

Comparative diagnostic utility ...... irment and Alzheimer's disease

@en

Comparative diagnostic utility ...... rment and Alzheimer's disease.

@nl

altLabel

Comparative Diagnostic Utility ...... irment and Alzheimer’s Disease

@en

prefLabel

Comparative diagnostic utility ...... irment and Alzheimer's disease

@en

Comparative diagnostic utility ...... rment and Alzheimer's disease.

@nl

P1433

Q37486254-61840200-D182-44AE-A6E8-401C01E2C4FA

P1476

Q37486254-33F56AB8-E3BC-4ABD-B8C1-B6D7AF84A7AB

P2093

Q37486254-04208A13-6582-4587-B8B3-03ECDFFF5BFB

Q37486254-371D8C39-0D7E-491D-9F63-F89F0218C7C4

Q37486254-3DE1E320-4CF7-4E7E-813D-CECA8DF226E0

Q37486254-57A8F8F4-9FB6-4801-B4EE-1C16B42E0137

Q37486254-6C411596-5EFF-4E6F-AAE8-4B349ED3F713

Q37486254-8CBC7BC8-6ECE-4E54-8A6F-C9D25B669DC8

Q37486254-967F315A-05DD-43AA-8DBD-BAA937AC8B38

Q37486254-99A890DC-A8F8-4624-B331-CD9355D19584

Q37486254-AE17BFF5-0EE9-433D-B789-4E0CED0C5CFB

P2860

Q37486254-0428C4CF-FBB7-43CB-8137-770D81941F0A

Q37486254-0749C6D6-B334-47FC-9177-C7D900A1BF76

Q37486254-18E34200-EA53-4BC3-9D81-F0E0A8D6CDB3

Q37486254-1EA9BEB6-47B0-4DCB-9CAE-838E80C90AC3

Q37486254-24770F48-9868-4F92-9011-B2936E44E7FA

Q37486254-29BC2A17-59A5-4E63-8F44-4BA6BEF322E1

Q37486254-2D09A0E3-2B92-438A-97B3-A0ADD5DF5381

Q37486254-2D83CDBF-133C-41E2-BC84-DB00A58D2C6B

Q37486254-3831F5FF-316E-4806-8A69-80CFE8E6E3E9

Q37486254-50BFD916-D5BB-498C-AD6A-D46D9A932863

P304

Q37486254-F061AC0A-B975-46F0-8481-CA31DB6D4B24

P31

Q37486254-6C12DAFE-F9DF-4DC8-B03C-1388C1540FB5

P356

Q37486254-09981081-77D4-47E6-8818-AC010709D2DE

P407

Q37486254-24463DEA-85E9-48A9-8FA5-626E33E2A679

P433

Q37486254-0F58FCAF-DE95-4FB7-A8E3-032F409CBED0

P478

Q37486254-DCBA5BAD-F9B3-4607-BFFF-359182C7A6F7

P50

Q37486254-3BC91387-9453-4005-97D3-4CBC18B07F88

Q37486254-4B223B5C-2786-4FF2-8F1E-C8F4623EB132

Q37486254-C1C1F0AF-91D7-4011-839A-892D833F759C

Q37486254-FA776B04-B40D-4C1A-B8EA-CCD53DAF6A11

P577

Q37486254-281315FA-F438-42D7-86FF-1E75F19DA500

P5875

Q37486254-F2B02BA5-7EAD-4CB5-BC38-35193DB60DAE

P698

Q37486254-6D68DD58-FAF4-4A21-80A2-4E3728E62975

P921

Q37486254-2fc71ff1-30a9-4f47-9e25-46036aabe75f

Q37486254-34A2AE9A-6172-409B-8742-E5C9EB49720B

P932

Q37486254-FF8658E3-E067-4911-8004-E02CD50158DA

P356

P1433

Dementia and Geriatric Cognitive Disorders

P1476

Comparative diagnostic utility ...... irment and Alzheimer's disease

@en

P2093

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

Emre Kokmen

http://www.w3.org/2001/XMLSchema#string

Eric G Tangalos

http://www.w3.org/2001/XMLSchema#string

Maria M Shiung

http://www.w3.org/2001/XMLSchema#string

Peter C O'Brien

http://www.w3.org/2001/XMLSchema#string

Robert J Ivnik

http://www.w3.org/2001/XMLSchema#string

Ruth H Cha

http://www.w3.org/2001/XMLSchema#string

Steven D Edland

http://www.w3.org/2001/XMLSchema#string

YueCheng Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Mild cognitive impairment: clinical characterization and outcome

The Clinical Dementia Rating (CDR): current version and scoring rules

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications.

Magnetic resonance spectroscopy in AD.

Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

P304

198-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000066021

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11052920

http://www.w3.org/2001/XMLSchema#string

P698

12411762

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2796574

http://www.w3.org/2001/XMLSchema#string